Arthritis-associated osteoclastogenic macrophage, AtoM, as a key player in pathological bone erosion

Tomoya Agemura1, Tetsuo Hasegawa1, Shinya Yari1

  • 1Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.

Insights

Researchers identified novel arthritis-associated osteoclastogenic macrophages (AtoMs) that drive inflammatory bone destruction. Advanced imaging reveals differences between physiological and pathological osteoclasts in living mice.

Area of Science:

  • Bone Biology
  • Immunology
  • Cellular Dynamics

Background:

  • Osteoclasts are crucial myeloid cells for bone homeostasis, balancing bone formation by osteoblasts.
  • Pathological osteoclasts, distinct from physiological ones, contribute to bone destruction under inflammation.
  • Understanding osteoclast behavior in vivo is key to addressing bone diseases.

Purpose of the Study:

  • To review in vivo imaging techniques for observing osteoclast dynamics.
  • To elucidate the differentiation mechanisms of physiological and pathological osteoclasts.
  • To introduce novel osteoclast precursors identified in arthritis.

Main Methods:

  • Utilizing advanced two-photon intravital microscopy for real-time observation of osteoclasts in living mouse bone marrow.
  • Characterizing osteoclast precursors in arthritic conditions.

Main Results:

  • Intravital imaging revealed distinct dynamics between physiological and pathological osteoclasts.
  • Identified arthritis-associated osteoclastogenic macrophages (AtoMs) as novel precursors.
  • AtoMs differentiate into pathological osteoclasts, causing inflammatory bone destruction.

Conclusions:

  • Arthritis-associated osteoclastogenic macrophages (AtoMs) are key players in inflammatory bone loss.
  • In vivo imaging provides critical insights into osteoclast function and differentiation.
  • Targeting AtoMs may offer a therapeutic strategy for inflammatory bone diseases.